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Abstract
Background: Neutrophil infiltration commonly occurs in acute lung injury and may be partly
responsible for the inflammatory response. However, acute lung injury still occurs in the
neutropenic host. The objectives of this study are to determine if inflammation and acute lung injury
are worse in neutropenic versus the normal host after endotoxemia.
Methods: Rats were divided into four groups: 1) control, 2) neutropenic, 3) endotoxemic and 4)
endotoxemic and neutropenic. Tumor necrosis factor (TNF)-α and macrophage inflammatory
protein (MIP-2) were measured in the blood, lung lavage and for mRNA in the lung. Arterial blood
gases were measured to determine the alveolar-arterial oxygen gradient which reflects on lung
injury.
Results: In endotoxemia, the neutropenic rats had lower plasma TNF-α (116 ± 73 vs. 202 ± 31
pg/ml) and higher plasma MIP-2 (26.8 + 11.9 vs. 15.6 + 6.9 ng/ml) when compared to non-
neutropenic rats. The endotoxemic, neutropenic rats had worse lung injury than the endotoxemic,
non-neutropenic rats as shown by increase in the alveolar-arterial oxygen gradient (24 ± 5 vs. 12
± 9 torr). However, lavage concentrations of TNF-α and MIP-2 were similar in both groups.
Conclusion: Neutrophils may regulate TNF-α and MIP-2 production in endotoxemia. The
elevation in plasma MIP-2 in the endotoxemic, neutropenic rat may be secondary to the lack of a
neutrophil response to inhibit production or release of MIP-2. In endotoxemia, the severe lung
injury observed in neutropenic rats does not depend on TNF-α or MIP-2 produced in the lung.
Background
Sepsis is a leading cause of morbidity and mortality in the
intensive care unit. Improvements in the treatment of can-
cer have led to a growing population of immunocompro-
mised patients with longer survival times and a propensity
to develop sepsis and acute respiratory distress syndrome
(ARDS) [1,2]. It is important to study the role of neu-
trophils in sepsis in order to better understand the effect
of neutropenia on the inflammatory response in sepsis.
Different treatment modalities may be necessary in the
neutropenic versus the non-neutropenic host.
Neutropenia is commonly induced by cyclophosphamide
in cancer-stricken patients. In these patients, white cells
are markedly diminished in number but not absent. It is
known that cyclophosphamide has effects on other cells
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in the body [3-5]. This drug may decrease the activity of
lymphoid cells and macrophages in the spleen [3,4].
Cyclophosphamide may also modulate CD4+ T cells into
a Th2 phenotype and cause a decrease IFN-gamma pro-
duction as in patients with multiple sclerosis [5]. How-
ever, in spite of the numerous cellular effects of
cyclophosphamide, in a study of endotoxemia-associated
acute lung injury, depletion of neutrophils by cyclophos-
phamide or anti-neutrophil antibodies showed no differ-
ence in lung injury as shown by lung edema or
inflammation as demonstrated by similar amounts of the
transcription factor, nuclear factor kappa B [6]. Cyclo-
phosphamide can be used to induce neutropenia because
of its widespread use in treatment regimens and the fact
that the effect is similar to anti-neutrophil antibodies
when studying acute lung injury secondary to endotox-
emia.
The immune response to sepsis has been widely studied in
the immunocompetent host. Sepsis leads to early release
of the cytokines; tumor necrosis factor (TNF)-α and inter-
leukin (IL)-1β which are primarily produced by macro-
phages [7]. Cytokines are low molecular weight proteins
(<30 kd) that are responsible for intercellular signaling
[8]. After TNF-α and IL-1β are released, their signals are
amplified many fold, leading to the activation of the
inflammatory cascade and consequently, inflammation.
The role of the neutrophil in producing or modulating
this initial cytokine response to sepsis has not been well
studied [6].
Recruitment of neutrophils in the lung for example,
depends on communication between endothelial, stro-
mal, parenchymal cells and the infiltrating neutrophils
[9]. These initial events are mediated by the early produc-
tion of cytokines, specialized cytokines called chemokines
and cell adhesion molecules [9]. Chemokines belong to a
superfamily of cytokines that promote chemotaxis of leu-
kocytes to areas of infection, tissue injury or neoplasia
[10]. Four subfamilies of chemokines are categorized
based on the spacing of the first two cysteine residues and
are designated as C, C-C, C-X-C, C-X3-C. In general, the C-
X-C group is responsible for neutrophil chemotaxis and
activation [11,12]. The most studied C-X-C chemokine in
humans is IL-8. No murine homolog for IL-8 has been dis-
covered but macrophage inflammatory protein (MIP)-2 is
one of its functional homologs [13]. In sepsis, the devel-
opment of acute lung injury may be secondary to activa-
tion of the inflammatory response.
Sepsis syndrome is the single most common risk factor
associated with the development of acute respiratory dis-
tress syndrome (ARDS) [14]. Inflammatory mediators
that may be produced as a result of sepsis are felt to play a
central role in the development of ARDS. Migration of
neutrophils to the lungs and disruption of the alveolar
capillary membrane characterizes early ARDS [7,15].
Mechanisms involved in recruiting neutrophils into the
lung have not been well established but are probably
dependent on chemotactic factors produced in the lung
[7,15].
The C-X-C chemokine, macrophage inflammatory protein
(MIP-2), contributes to increasing neutrophil chemotaxis
in murine acute lung injury [16-23]. Lipopolysaccharide,
TNF-α and/or IL-1β have been reported to stimulate the
production of these cytokines in the lung [19,22]. In the
neutropenic host, neutrophil adhesion and chemotaxis
may be abnormal due to insufficient production of chem-
okines or disruption of at feedback mechanisms. Regula-
tion of the inflammatory response by neutrophils is
unknown and has not been well studied.
The first objective of this study is to determine if TNF-α,
IL-1β and MIP-2 concentrations will be lower in the sys-
temic circulation of neutropenic, endotoxemic rats com-
pared to non-neutropenic, endotoxemic rats. The second
objective is to ascertain if acute lung injury will be worse
secondary to the increased production of TNF-α, IL-1β
and MIP-2 in the lungs of the non-neutropenic, endotox-
emic rats versus the neutropenic endotoxemic rats.
Materials and methods
This study was approved by the Animal Investigation
Committee at Wayne State University and performed in
accordance with the NIH guidelines for the use of animals
in research. Male Sprague-Dawley rats weighing 250–400
g were divided into one of four groups: 1) normal control
(n = 6), 2) neutropenic control (n = 6), 3) normal, endo-
toxemia (n = 12) and 4) neutropenic and endotoxemia (n
= 12).
Neutropenia
Three days prior to study, rats received 100 mg/kg of
cyclophosphamide (Sigma, USA) by intraperitoneal (IP)
injection. Control rats received an equal volume of 0.9%
sodium chloride. Neutropenia was confirmed by absolute
neutrophil counts of less than 1000/μl.
Endotoxin administration
Rats in the endotoxemia group were given E. Coli 0127:B8
lipopolysaccharide (10 mg/kg) by IP injection (Sigma,
USA). Control rats received an equal volume of 0.9%
sodium chloride.
Experimental protocol
Four hours after endotoxin or saline, the rats were sedated
and anesthetized with ketamine (60 mg/kg) and xylazine
(5 mg/kg). The right femoral artery was catheterized and
mean arterial blood pressure and heart rate were recorded.
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Blood was removed for blood gases (Radiometer, ABL5,
Westlake, OH) TNF-α, IL-1β and MIP-2. The rats were sac-
rificed. The right hilum was clamped and the right lower
lobe of the lung was removed and placed in TRI Reagent,
a RNA isolation reagent. The right ventricle was cannu-
lated and the pulmonary circulation of the left lung was
perfused with cold phosphate buffered saline until clear.
The left lung was washed with 25 ml of warm (37°C)
phosphate buffered saline. The bronchoalveolar lavage
(BAL) fluid was centrifuged at 1200 rpm at 4°C for 7 min-
utes. The supernatant was stored at -70°C until analyzed.
TNF-α, IL-1β and MIP-2 protein determination
TNF-α, IL-1β and MIP-2 were measured using a commer-
cially available enzyme linked immunosorbent assay
(ELISA) (Biosource International Inc, Camarillo, CA). In
brief, plasma, BAL or known control samples were placed
in a 96 well microtiter plate previously coated with mon-
oclonal antibodies to TNF-α, IL-1β or MIP-2 respectively.
A second biotinylated antibody, was added to bind to the
complex followed by an enzyme horseradish peroxidase,
thus forming a four-member sandwich. After addition of
a substrate solution, the bound enzyme acts to produce
color. The optical density was measured in a spectropho-
tometer at 450 nm. Concentrations of TNF-α, IL-1β or
MIP-2 were determined by interpolation from the stand-
ard curve. The sensitivities for TNF-α, IL-1β and MIP-2
were <4 pg/ml, <1 pg/ml and <1 pg/ml respectively.
TNF-α, IL-1β, and MIP-2 mRNA determination
Lung tissue mRNA was extracted as recommended by the
manufacturer (Sigma, St. Louis, MO). In brief, after the
lung tissue was homogenized, chloroform was added and
the mixture was centrifuged. Absolute ethanol was added
to the aqueous phase. After centrifugation, 75% ethanol
was added to the RNA pellet. Again, the sample was cen-
trifuged, the supernatant discarded, and the RNA pellet
was placed in DEPC water. The sample was stored at -
20°C until analysis.
Aliquots of the total RNA (30 μg) were resolved by formal-
dehyde-agarose gel electrophoresis and integrity and con-
centration of RNA was verified by staining with ethidium
bromide. Reverse transcription of RNA (0.0625 mcg) was
accomplished by (25°C for 10 minutes followed by 42°C
for 60 minutes) using 5× buffer (Gibco BRL), 250 mM
KCl, random primers (18 OD units), RNase inhibitor and
AMV reverse transcriptase enzyme (Gibco, BRL). The RNA
was then amplified by polymerase chain reaction (PCR).
Optimal conditions for TNF-α, IL-1β, MIP-2, and β-actin
mRNA were established in our laboratory prior to study.
Amplification was performed in 50 μl reaction buffer con-
taining 20 mM TRIS pH 8.0, 50 mM KCl, 25 mM MgCl2,
Taq DNA polymerase enzyme (Gibco, BRL), 2.5 mM each
of dNTPs (dTTP, dGTP, dATP), 0.3 microCi dCTP radio
labeled with P32 and 2 μl of TNF-α, IL-1β, MIP-2, or β-
actin primers (Biosource International, Camarillo, CA)
respectively. The primers spanned an intron so that
genomic DNA contamination would not interfere with
the analyses. After denaturation for 90 sec, the thermo
cycling conditions were 30 sec at 94°C, 45 sec at 72°C, 45
sec at 72°C followed by 7 min extension step at 72°C.
PCR was performed with 26 cycles for TNF-α, IL-1β, and
MIP-2 mRNA respectively and 21 cycles for β-actin.
A polyacrylamide gel electrophoresis (4% AA in 1% TBE
buffer) was used to separate the amplified cDNA frag-
ments. TNF-α, IL-1β, MIP-2, and β-actin mRNA were
detected after exposing the gel to radiographic film. The
density of the autoradiograph bands was measured using
computer software (Kodak Science 1D). Relative TNF-α,
IL-1β, or MIP-2 mRNA levels were estimated as the ratio
of the autoradiographic density of TNF-α, IL-1β, or MIP-2
mRNA to the internal standard, β-actin mRNA.
Statistical analysis
The values are expressed as mean ± standard deviation.
The factors were compared using one-way ANOVA. A p
value of < 0.05 was considered significant. If the one-way
ANOVA was significant, a post hoc analysis using Games-
Howell was used to determine the significance between
the groups. Statistical analyses were performed using SPSS
11.5 software.
Results
Cardiovascular
All 4 groups had similar heart rate and mean blood pres-
sure (table 1).
Respiratory
The pO2 was higher in the control and neutropenic when
compared to the endotoxemic groups. However, among
the endotoxemic rats, the neutropenic group had a lower
pO2 compared to the non-neutropenic group. Likewise,
the A-a O2 gradient was lower in the control and neutro-
penic when compared to the endotoxemic groups. The A-
a O2 gradient was higher in the neutropenic, endotoxemic
compared to the non-neutropenic, endotoxemic group.
The pH and pCO2 were similar in all groups (table 1).
Inflammation
Neutropenic, endotoxemic rats had less pulmonary
mRNA for TNF-α when compared to normal, endotox-
emic rats. No mRNA for TNF-α was detected in the lungs
of the control or neutropenic rats (figure 1). Likewise,
among endotoxemic rats, the plasma TNF-α concentra-
tion was less in the neutropenic compared to the normal
group. No plasma TNF-α was detected in either the con-
trol or neutropenic groups (figure 1). The TNF BAL con-
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centration was similar in all four groups (77 ± 40 pg/ml
for control, 68 ± 33 pg/ml for neutropenic, 61 ± 35 pg/ml
for LPS, and 81 ± 54 pg/ml for neutropenic, LPS).
Plasma concentrations of MIP-2 were elevated in the
endotoxemic, neutropenic rats when compared to the
endotoxemic, normal rats (figure 2). However, pulmo-
nary mRNA for MIP-2 was similar in both endotoxemic
groups. In control and neutropenic rats, no mRNA for
MIP-2 was detected in the lung. Lung lavage concentra-
tions of MIP-2 were higher in the endotoxemic rats com-
pared to the control and neutropenic groups. However,
the MIP-2 lung lavage concentrations were similar in the
endotoxemic groups regardless of the presence or absence
of neutropenia (figure 2).
Endotoxemic, neutropenic rats had similar amounts of
mRNA for IL-1β in the lung compared to endotoxemic,
normal rats (0.51 ± 0.19 vs. 0.87 ± 0.43, densitometry
readings IL-1β mRNA/β-actin mRNA, post hoc analysis, p
= 0.32). The control and neutropenic rats had no detec-
tion of mRNA for IL-1β (one-way ANOVA, p < 0.05 for
endotoxemic vs. non-endotoxemic rats). IL-1β was not
detected in the plasma or lavage of any of the groups.
Discussion
The early effect of endotoxin on cytokine production in
the systemic circulation has not been well studied in the
neutropenic host. We compared the early production of
TNF-α, IL-1β, and MIP-2 in the systemic circulation of
neutropenic and non-neutropenic rats after endotoxin
administration. In this model of endotoxemia, the TNF-α
concentration was markedly decreased while MIP-2 was
elevated in the plasma of the neutropenic, endotoxemic
compared to non-neutropenic, endotoxemic rats. IL-1β
was not detected in either group. Previous studies have
shown that the early response to endotoxin would be an
elevation in TNF-α and IL-1β followed by a rise in MIP-2
production [23,24]. Thus, it appears that the neutrophil is
involved directly or indirectly in increasing TNF-α produc-
tion in the systemic circulation after endotoxemia. Neu-
trophils may effect their own recruitment into the
systemic circulation by down-regulating the production of
the chemokine MIP-2. In this model of early endotox-
emia, IL-1β production is not yet present in the systemic
circulation. In endotoxemia, cytokines from the systemic
circulation can increase the permeability of the endothe-
lium of the alveolar capillaries thus precipitating acute
lung injury [25].
In our study, acute lung injury as shown by increased A-a
O2 gradient developed within 4 hours of the administra-
tion of endotoxin in both neutropenic and non-neutro-
penic rats. The neutropenic rats had evidence of more
severe lung injury when compared to the non-neutro-
penic rats. Tumor necrosis factor-α plays an important
role in initiating acute lung injury after endotoxemia in
the normal host [26,27]. However, the influence of neu-
trophils on the production of TNF-α is controversial
[6,28-32]. In an endotoxemia model, pulmonary mRNA
and protein concentration of TNF-α were similar in both
neutropenic and non-neutropenic mice. Alternatively, in
the same study, elevations in pulmonary mRNA and pro-
tein concentration of TNF-α were observed in a neutro-
penic compared to non-neutropenic mouse hemorrhagic
shock model [6]. In a study where pulmonary TNF-α
mRNA and TNF-α in lung homogenates were compared
in neutropenic rats given granulocyte colony stimulating
factor (GCSF) for recovery versus placebo, the GCSF group
had higher amounts of TNF-α mRNA and TNF-α in lung
homogenates [33]. This suggests that the neutrophils play
a role in causing a rise in TNF-α either by producing TNF-
α or influencing other cells to produce it. In our study,
endotoxemia did not lead to the TNF-α production in the
lung. However, the mRNA for TNF-α was decreased in the
lungs of the neutropenic, endotoxemic versus the non-
neutropenic, endotoxemic rats. This suggests that the pres-
ence of neutrophils may alter the production of TNF-α in
the lung which then may influence the inflammatory
response later in the course of endotoxemia. The observed
differences between studies may be a function of timing.
Measurements of TNF-α at numerous time points may be
beneficial.
In addition to TNF-α, IL-1β may play a significant role in
the development of acute lung injury [15]. Pulmonary
Table 1: Hemodynamic and Arterial Blood Gases Data
Control Neutropenic LPS Neutropenic LPS
Heart rate (bpm) 240 ± 44 238 ± 16 280 ± 38 258 ± 42
Mean blood pressure (mm 
Hg)
100 ± 18 107 ± 10 113 ± 20 104 ± 18
pH 7.37 ± .03 7.39 ± .09 7.29 ± .03 7.32 ± .07
pCO2 (torr) 47 ± 6 45 ± 11 48 ± 5 46 ± 4
pO2(torr) 92 ± 6 84 ± 4 80 ± 6* 69 ± 6 **
A-a O2 gradient (torr) 2 ± 2 8 ± 7 12 ± 9* 24 ± 5 **
*Group is different than control group, ** Group is different than all other groups p < 0.05, one-way ANOVA, post hoc test Games-Howell
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mRNA and protein for IL-1β, one of the earliest inflamma-
tory cytokines, has been shown to be suppressed in neu-
tropenic mice who received endotoxin by intraperitoneal
injection [6]. In neutropenic rats that received GCSF prior
to acute lung injury, the lung homogenate IL-1β concen-
tration was much higher when compared to those neutro-
penic rats that did not receive GCSF suggesting that the
increased number of neutrophils was responsible for IL-
1β production [33]. In our study, neutropenic rats tended
to have decreased amounts of pulmonary IL-1β mRNA
when compared to non-neutropenic, endotoxemic rats;
however the difference was not significant. IL-1β was not
detected in the lung lavage. It is possible that in this early
model of endotoxemia, IL-1β was not yet produced.
Endotoxemia affected the production of MIP-2 in the lav-
age and mRNA for MIP-2 in the lung when compared to
control rats. However, the concentration of MIP-2 in the
lavage and the detection of mRNA for MIP-2 were similar
in both the neutropenic and non-neutropenic groups. It is
likely that neutrophil chemotaxis has not yet occurred and
therefore feedback inhibition by the neutrophil has not
transpired at this time point. PMN staining would provide
evidence for chemotaxis/no-chemotaxis at this time
point.
In spite of the fact that the cytokine production in the lung
was similar in both endotoxemic groups, acute lung injury
was more severe in the neutropenic compared to the non-
Comparison of lung mRNA, plasma and lavage concentrations of TNF-α in the control, neutropenic, non-neutropenic, LPS and neutropenic, LPS groupsFigure 1
Comparison of lung mRNA, plasma and lavage concentrations of TNF-α in the control, neutropenic, non-neu-
tropenic, LPS and neutropenic, LPS groups. * Plasma TNF-α is higher in normal, endotoxemic rats compared to all 
other groups, ** Endotoxemic group is different than the other 3 groups for lung mRNA TNF-α, *** Plasma TNF-α is higher in 
neutropenic, endotoxemic rats compared to control and neutropenic groups, p < 0.05, one-way ANOVA, post hoc test 
Games-Howell.
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neutropenic, endotoxemic rat. An increase in pulmonary
vascular resistance or a decline in arterial oxygenation are
the first indicators of acute lung injury [34]. Early in acute
lung injury, low oxygenation can be the result of ventila-
tion perfusion mismatch [25]. This can develop as a result
of an imbalance of the effect of vasodilators and vasocon-
strictors on the pulmonary vascular endothelium [34-36].
In addition, some studies suggest that a decreased
endothelium-dependent relaxation and increased con-
strictor response results in spite of expression of inducible
nitric oxide synthase and the release of nitric oxide [37-
39]. As lung injury progresses, pulmonary edema which
develops in part due to cytokines, plays a role in decline
in oxygenation [25]. In our study, in the absence of
cytokine production in the lung, it is possible that pulmo-
nary hypertension due to an imbalance of vasodilators
and vasoconstrictors or impaired sensitivity to vasoactive
mediators is the cause of the low oxygenation. Further
investigation into the cause of this early deterioration in
lung function is warranted.
Conclusion
Neutropenia is associated with the production or regula-
tion of TNF-α in endotoxemia. Likewise, neutrophils may
influence their own chemotaxis by regulating MIP-2 pro-
duction in endotoxemia. However, neutrophils may act
indirectly by regulating cytokine production in other
inflammatory cells. Further investigation is required to
determine how the neutrophil influences the inflamma-
tory process in sepsis.
Comparison of mRNA, plasma and lavage concentrations of MIP-2 in the control, neutropenic, endotoxemic and neutropenic, endotoxemic groupsFigure 2
Comparison of mRNA, plasma and lavage concentrations of MIP-2 in the control, neutropenic, endotoxemic 
and neutropenic, endotoxemic groups. * Plasma MIP-2 is higher in endotoxemic rats compared to control and neutro-
penic groups but lower than neutropenic, endotoxemic rats, ** Plasma MIP-2 is higher in the endotoxemic, neutropenic group 
compared to all other groups, p < 0.05, one-way ANOVA, post hoc test Games-Howell.
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In early endotoxemia, the more severe lung injury
observed in neutropenic compared to non-neutropenic
rats does not depend on TNF-α, IL-1β and MIP-2 in the
lung. In fact, the neutrophil may be responsible for indi-
rectly injuring the lung by its influence on the macro-
phage or endothelial cell such as in nitric oxide
production.
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